{"id":170558,"date":"2025-08-25T05:53:26","date_gmt":"2025-08-25T09:53:26","guid":{"rendered":"https:\/\/44.250.171.167\/?p=170558"},"modified":"2025-08-25T13:29:33","modified_gmt":"2025-08-25T17:29:33","slug":"alembic-q1-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/alembic-q1-fy26-earnings-results\/","title":{"rendered":"Alembic Q1 FY26 Earnings Results"},"content":{"rendered":"<p>Alembic Ltd, established in 1907, operates in the pharmaceuticals, real estate, and power assets sectors. It is the flagship company of the Alembic Group and holds significant stakes in Alembic Pharma Ltd and Paushak Limited. Presenting below its Q1 FY26 Earnings Results.<\/p>\n<h2><strong>Q1 FY26 Earnings Results<\/strong><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> \u20b950 crore, down 1.96% year-on-year (YoY) from \u20b951 crore in Q1 FY25.<\/li>\n<li><strong>Total Expenses:<\/strong> \u20b934 crore, up 6.25% YoY from \u20b932 crore.<\/li>\n<li><strong>Consolidated Net Profit (PAT):<\/strong> \u20b962 crore, up 10.71% from \u20b956 crore in the same quarter last year.<\/li>\n<li><strong>Earnings Per Share (EPS):<\/strong> \u20b92.40, up 10.60% from \u20b92.17 YoY.<\/li>\n<\/ul>\n<h2><strong>Operational &amp; Strategic Update<\/strong><\/h2>\n<ul>\n<li><strong>Slight Revenue Decline:<\/strong> Revenues fell marginally by approximately 2%, indicating stable but slightly soft business activity.<\/li>\n<li><strong>Expense Increase:<\/strong> Total expenses rose by over 6%, reflecting higher operational or administrative costs.<\/li>\n<li><strong><a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/2803dcea-95ce-4b79-95dc-b3a9aa2073b0.pdf\" target=\"_blank\" rel=\"noopener\">Profit Growth<\/a><\/strong><strong>:<\/strong> Net profit and EPS increased by more than 10%, signaling improved profitability despite flat revenues, likely due to other income or operational efficiencies.<\/li>\n<li><strong>Market Position:<\/strong> Alembic Ltd continues to maintain a strategic position in pharmaceuticals and real estate, backed by its stakes in key group entities.<\/li>\n<li><strong>Strategic Focus:<\/strong> The company focuses on optimizing asset value, enhancing operational efficiency, and capitalizing on its diversified business portfolio.<\/li>\n<\/ul>\n<h2><strong>Corporate Developments in Q1 FY26 Earnings<\/strong><\/h2>\n<p><a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/2803dcea-95ce-4b79-95dc-b3a9aa2073b0.pdf\" target=\"_blank\" rel=\"noopener\">Q1 FY26<\/a> results demonstrate Alembic Ltd\u2019s ability to generate profit growth amid a stable revenue environment through effective cost management and value realization.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-170559\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/alembic.png\" alt=\"ALEMBICLTD Q1 FY26 Earnings Results\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/alembic.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/alembic-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/alembic-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/alembic-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/alembic-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n<h2><strong>Looking Ahead<\/strong><\/h2>\n<p>Alembic Ltd aims to sustain profitability by continuing operational improvements, maximizing group synergies, and leveraging its diverse business assets to drive long-term growth.<\/p>\n<p>Explore the company\u2019s past earnings and latest concall transcripts,<a href=\"https:\/\/44.250.171.167\/symbol\/alembicltd\/\"> click here<\/a> to visit the AlphaStreet India News Channel.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alembic Ltd, established in 1907, operates in the pharmaceuticals, real estate, and power assets sectors. It is the flagship company of the Alembic Group and holds significant stakes in Alembic Pharma Ltd and Paushak Limited. Presenting below its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b950 crore, down 1.96% year-on-year (YoY) from \u20b951 [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":170559,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[1115],"class_list":["post-170558","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/alembic.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":169930,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-q1-fy26-earnings-results-revenue-up-10-net-profit-rises-14-yoy\/","url_meta":{"origin":170558,"position":0},"title":"Alembic Pharmaceuticals Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 8, 2025","format":false,"excerpt":"Alembic Pharmaceuticals Limited is a leading player in the pharmaceutical industry, engaged in the development, manufacturing, and marketing of formulations and active pharmaceutical ingredients (APIs). The company operates 3 R&D centers and 5 advanced manufacturing facilities, supporting global exports and a robust domestic presence. Presenting below are its Q1 FY26\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"APLLTD Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172973,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-q2-fy26-earnings-results\/","url_meta":{"origin":170558,"position":1},"title":"Alembic Pharmaceuticals Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"December 10, 2025","format":false,"excerpt":"Alembic Pharmaceuticals Ltd, engaged in development, manufacturing, and marketing of formulations and APIs with 3 R&D and 5 manufacturing facilities, posted robust earnings growth in Q2FY26. Financial Highlights: Revenues increased 15.9% year-on-year to \u20b91,910 crore from \u20b91,648 crore, led by strong growth in US generics, ex\u2011US markets, and APIs. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AP.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AP.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AP.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AP.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AP.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AP.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147370,"url":"https:\/\/alphastreet.com\/india\/earnings-alembic-pharmaceuticals-limited-nse-aplltd-q4fy23-results-out-total-income-fell-1-yoy\/","url_meta":{"origin":170558,"position":2},"title":"Earnings | Alembic Pharmaceuticals Limited (NSE: APLLTD): Q4FY23 Results Out; Total Income fell 1% YoY.","author":"Divyansh_Kasana","date":"May 26, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is a leading player in the pharmaceutical industry, specializing in the development, manufacturing, and marketing of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). The company boasts three research and development (R&D) facilities dedicated to innovative drug development and technological advancements. With a strong focus on quality\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":145171,"url":"https:\/\/alphastreet.com\/india\/earnings-alembic-pharmaceuticals-limited-nse-aplltd-q4fy23-results-out-total-income-fell-1-3-yoy\/","url_meta":{"origin":170558,"position":3},"title":"Earnings | ALEMBIC PHARMACEUTICALS LIMITED (NSE: APLLTD): Q4FY23 Results Out; Total Income fell 1.3% YoY.","author":"Divyansh_Kasana","date":"May 5, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients. Founded in 1907, the company has a strong focus on research and development, and has invested heavily in state-of-the-art facilities and advanced\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":141223,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-nse-aplltd-q3-fy23-results-out-total-income-rises-18-yoy\/","url_meta":{"origin":170558,"position":4},"title":"Alembic Pharmaceuticals LTD. (NSE: APLLTD): Q3 FY23 Results Out; Total Income Rises 18% YoY","author":"Divyansh_Kasana","date":"February 13, 2023","format":false,"excerpt":"Alembic Pharmaceuticals Ltd. (NSE:APLLTD) is an Indian pharmaceutical company that was founded in 1907. It is headquartered in Vadodara, Gujarat, and operates globally. The company specializes in the manufacturing of a wide range of pharmaceutical products, including active pharmaceutical ingredients, formulations, and nutraceuticals. Alembic Pharmaceuticals is known for its high-quality\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":152547,"url":"https:\/\/alphastreet.com\/india\/alembic-ltd-q1fy24-68-rise-in-revenue\/","url_meta":{"origin":170558,"position":5},"title":"Alembic Ltd Q1FY24; 68% rise in Revenue","author":"Divyansh_Kasana","date":"August 10, 2023","format":false,"excerpt":"Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-625.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=170558"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170558\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/170559"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=170558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=170558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=170558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}